MARKET COMPOSITE
PCRX - Pacira BioSciences Inc6:10:11 PM 3/28/2024
Price
$29.33
+ 0.29 (1.00%)
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company has collaboration with Aetna. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue181.2MM+11%
Gross Profit133.6MM-
Cost Of Revenue47.7MM+20%
Operating Income33.2MM+87%
Operating Expenses100.4MM-
Net Income24.9MM-
R&D19.5MM-7%
G&A65.8MM-3%
Amortization14.3MM-
Interest Expense3.4MM-2%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news